-
International Journal of Chronic Obstructive Pulmonary Disease
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Development and implementation of treadmill exercise testing protocols in COPD
Original Research
(2300) Views (988) Full article downloads
Authors: Christopher B Cooper, Marlon Abrazado, Daniel Legg, et al
Published Date October 2010
Volume 2010:5 Pages 375 - 385
DOI: http://dx.doi.org/10.2147/COPD.S11153
Christopher B Cooper1, Marlon Abrazado1, Daniel Legg2, Steven Kesten2
1David Geffen School of Medicine, University of California, Los Angeles, CA, USA; 2Boehringer Ingelheim Pharmaceuticals Inc., Ingelheim, Germany
Background: Because treadmill exercise testing is more representative of daily activity than cycle testing, we developed treadmill protocols to be used in various clinical settings as part of a two-year, multicenter, chronic obstructive pulmonary disease (COPD) trial evaluating the effect of tiotropium on exercise.
Methods: We enrolled 519 COPD patients aged 64.6 ± 8.3 years with a postbronchodilator forced expiratory volume in one second (FEV1) of 1.25 ± 0.42 L, 44.3% ± 11.9% predicted. The patients performed symptom-limited treadmill tests where work rate (W) was increased linearly using speed and grade adjustments every minute. On two subsequent visits, they performed constant W tests to exhaustion at 90% of maximum W from the incremental test.
Results: Mean incremental test duration was 522 ± 172 seconds (range 20–890), maximum work rate 66 ± 34 watts. For the first and second constant W tests, both at 61 ± 33 watts, mean endurance times were 317 ± 61 seconds and 341 ± 184 seconds, respectively. The mean of two tests had an intraclass correlation coefficient of 0.85 (P < 0.001). During the second constant W test, 88.2% of subjects stopped exercise because of breathing discomfort; 87.1% for Global Initiative for Chronic Obstructive Lung Disease (GOLD) Stage II, 88.5% for GOLD Stage III, and 90.2% for GOLD Stage IV.
Conclusion: The symptom-limited incremental and constant work treadmill protocol was well tolerated and appeared to be representative of the physiologic limitations of COPD.
Keywords: chronic obstructive pulmonary disease, exercise testing, endurance, tiotropium
Other articles by Dr Christopher Cooper
Tiotropium reduces risk of exacerbations irrespective of previous use of inhaled anticholinergics in placebo-controlled clinical trials
Readers of this article also read:
Fatigue in patients with COPD participating in a pulmonary rehabilitation program
COPD is frequent in conditions of comorbidity in patients treated with various diseases in a university hospital
Direct costs of chronic obstructive pulmonary disease among managed care patients
Budesonide/formoterol combination in COPD: a US perspective
Tiotropium Respimat® improves physical functioning in chronic obstructive pulmonary disease
Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors
Cardiac injury in patients with COPD presenting with dyspnea: a pilot study
In search of parsimony: reliability and validity of the Functional Performance Inventory-Short Form
Association between lung function and exacerbation frequency in patients with COPD
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Clinical effectiveness of the Respimat® inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
- Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
- The pathophysiology of bronchiectasis
- Exacerbation rate, health status and mortality in COPD – a review of potential interventions




